Kiniksa Pharmaceuticals Statistics
Total Valuation
KNSA has a market cap or net worth of $1.31 billion. The enterprise value is $1.11 billion.
| Market Cap | 1.31B |
| Enterprise Value | 1.11B |
Important Dates
The next estimated earnings date is Tuesday, July 23, 2024, before market open.
| Earnings Date | Jul 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KNSA has 71.08 million shares outstanding. The number of shares has increased by 1.26% in one year.
| Shares Outstanding | 71.08M |
| Shares Change (YoY) | +1.26% |
| Shares Change (QoQ) | -9.25% |
| Owned by Insiders (%) | 4.28% |
| Owned by Institutions (%) | 99.19% |
| Float | 14.16M |
Valuation Ratios
The trailing PE ratio is 153.75 and the forward PE ratio is 195.55.
| PE Ratio | 153.75 |
| Forward PE | 195.55 |
| PS Ratio | 4.35 |
| Forward PS | 2.94 |
| PB Ratio | 3.04 |
| P/FCF Ratio | 61.38 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 128.33 |
| EV / Sales | 3.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 51.96 |
Financial Position
The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.21 |
| Quick Ratio | 3.57 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.57 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.10% and return on invested capital (ROIC) is -6.88%.
| Return on Equity (ROE) | 2.10% |
| Return on Assets (ROA) | 1.70% |
| Return on Capital (ROIC) | -6.88% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | $29,125 |
| Employee Count | 297 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | -30.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.74% in the last 52 weeks. The beta is 0.33, so KNSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +33.74% |
| 50-Day Moving Average | 19.01 |
| 200-Day Moving Average | 18.16 |
| Relative Strength Index (RSI) | 45.82 |
| Average Volume (20 Days) | 450,786 |
Short Selling Information
The latest short interest is 4.66 million, so 6.56% of the outstanding shares have been sold short.
| Short Interest | 4.66M |
| Short Previous Month | 4.12M |
| Short % of Shares Out | 6.56% |
| Short % of Float | 32.92% |
| Short Ratio (days to cover) | 16.59 |
Income Statement
In the last 12 months, KNSA had revenue of $301.77 million and earned $8.65 million in profits. Earnings per share was $0.12.
| Revenue | 301.77M |
| Gross Profit | 264.82M |
| Operating Income | -30.54M |
| Pretax Income | -21.56M |
| Net Income | 8.65M |
| EBITDA | -16.36M |
| EBIT | -21.56M |
| Earnings Per Share (EPS) | $0.12 |
Balance Sheet
The company has $213.55 million in cash and $12.14 million in debt, giving a net cash position of $201.41 million or $2.83 per share.
| Cash & Cash Equivalents | 213.55M |
| Total Debt | 12.14M |
| Net Cash | 201.41M |
| Net Cash Per Share | $2.83 |
| Equity (Book Value) | 431.90M |
| Book Value Per Share | 6.08 |
| Working Capital | 206.38M |
Cash Flow
In the last 12 months, operating cash flow was $21.56 million and capital expenditures -$190,000, giving a free cash flow of $21.37 million.
| Operating Cash Flow | 21.56M |
| Capital Expenditures | -190,000 |
| Free Cash Flow | 21.37M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 87.75%, with operating and profit margins of -10.12% and 2.87%.
| Gross Margin | 87.75% |
| Operating Margin | -10.12% |
| Pretax Margin | -7.15% |
| Profit Margin | 2.87% |
| EBITDA Margin | -5.42% |
| EBIT Margin | -7.15% |
| FCF Margin | 7.08% |
Dividends & Yields
KNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.26% |
| Shareholder Yield | -1.26% |
| Earnings Yield | 0.66% |
| FCF Yield | 1.63% |
Analyst Forecast
The average price target for KNSA is $30.20, which is 63.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.20 |
| Price Target Difference | 63.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 22.67% |
| EPS Growth Forecast (5Y) | 34.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Jun 28, 2024 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
KNSA has an Altman Z-Score of 8.55 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.55 |
| Piotroski F-Score | 4 |